| Literature DB >> 22792448 |
A M Edwards1, G P Maguire, D Graham, V Boland, G Richardson.
Abstract
Objective. To examine whether a programme of inspiratory muscle training (IMT) improves accumulative distance of self-paced walking in overweight and obese adults. Methods. A total of 15 overweight and obese adults were randomized into experimental (EXP: n = 8) and placebo (PLA: n = 7) groups. Lung function, inspiratory muscle performance, 6-minute walking test, and predicted [Formula: see text]O(2) max were assessed prior to and following the 4-week IMT intervention. Both groups performed 30 inspiratory breaths, twice daily using a proprietary inspiratory resistance device set to 55% of baseline maximal effort (EXP), or performing the same inspiratory training procedure at the minimum resistive setting (PLA). Results. Lung function was unchanged in both groups after-training; however inspiratory muscle strength was significantly improved in EXP (19 ± 25.2 cm H(2)O gain; P < 0.01) but did not significantly change in PLA. Additionally, the posttraining distance covered in the 6-minute walking test was significantly extended for EXP (62.5 ± 37.7 m gain; P < 0.01), but not for PLA. A positive association was observed between the change (%) of performance gain in the 6-minute walking test and body mass index (r = 0.736; P < 0.05) for EXP. Conclusion. The present study suggests that IMT provides a practical, minimally intrusive intervention to significantly augment both inspiratory muscle performance and walking distance covered by overweight and obese adults in a clinically relevant 6-minute walk test. This indicates that IMT may provide a useful priming (preparatory) strategy prior to entry in a physical training programme for overweight and obese adults.Entities:
Year: 2012 PMID: 22792448 PMCID: PMC3390056 DOI: 10.1155/2012/918202
Source DB: PubMed Journal: J Obes ISSN: 2090-0708
Participants' characteristics.
| EXP | PLA | |
|---|---|---|
| ( | ( | |
| Age (years) | 49 ± 8.6 | 55 ± 11.0 |
| Height (cm) | 173.4 ± 9.3 | 165.9 ± 10.8 |
| Mass (kg) | 112.7 ± 36.9 | 90.5 ± 16.6 |
| BMI (kg/m2) | 34.5 ± 8.4 | 32.8 ± 4.8 |
| Systolic blood pressure (mm Hg) | 135.9 ± 15.1 | 135.7 ± 12.7 |
| Diastolic blood pressure (mm Hg) | 87.8 ± 13.5 | 88.7 ± 20.7 |
Mean ± SD. There were no statistically significant differences between the physical characteristics of EXP and PLA groups.
Figure 1Distance covered (metres) in response to the 6-minute walk test for both experimental (EXP; n = 8) and placebo (PLA; n = 7) groups. * = significant difference between baseline and posttraining distance covered (P < 0.01). Means ± SD and individual (before and after training) results are displayed.
Lung function and estimated maximal aerobic power variables prior to and following the 4-week intervention period.
| EXP | PLA | |||
|---|---|---|---|---|
| Pre ( | Post ( | Pre ( | Post ( | |
| FVC (l) | 3.3 ± 0.9 | 3.0 ± 0.8 | 2.8 ± 0.8 | 2.7 ± 0.7 |
| FEV1 (l) | 2.8 ± 0.6 | 2.7 ± 0.7 | 2.5 ± 0.5 | 2.5 ± 0.5 |
|
| 41.7 ± 11.1 | 41.6 ± 10.7 | 42.3 ± 11.6 | 42.4 ± 11.6 |
Mean ± SD.
Figure 2Maximal inspiratory mouth pressure (MIP) measure before and after the 4-week intervention period for both experimental (EXP) and placebo (PLA) groups. * = significant difference between baseline (before) and posttraining (after) distance covered (P < 0.01).
Figure 3Associations between (a) body mass index and % change in 6-minute walking distance from pre- to posttraining and (b) between the (%) changes of maximal inspiratory mouth pressure and 6-minute walking distance from pre- to posttraining.